Christopher B. Ehrlich - Oct 4, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Stock symbol
EFTR
Transactions as of
Oct 4, 2022
Transactions value $
$197
Form type
4
Date filed
10/6/2022, 08:30 AM
Previous filing
Sep 27, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $197 +346 +0.99% $0.57 35.2K Oct 4, 2022 Direct
holding EFTR Common Stock 142K Oct 4, 2022 By Locust Walk Partners LLC F1
holding EFTR Common Stock 1.03K Oct 4, 2022 By Locust Walk Partners LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.